Open AccessClinical efficacy and safety of ivermectin (400 ug/kg, single dose) in patients with severe COVID-19: a randomized clinical trial
Author(s) -
Francisco Ochoa-Jaramillo,
Federico Rodriguez-Vega,
Nora CardonaCastro,
Verónica Posada-Vélez,
Diego Fernando RojasGualdrón,
Heidy Contreras-Martinez,
Ana María Romero-Millán,
Jessica Paola Porras Mancilla
Publication year - 2022
Publication title -
infectio
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.16
H-Index - 9
eISSN - 2422-3794
pISSN - 0123-9392
DOI - 10.22354/24223794.1105
Subject(s) - medicine , ivermectin , placebo , hazard ratio , adverse effect , mechanical ventilation , randomized controlled trial , clinical trial , clinical endpoint , single center , anesthesia , confidence interval , veterinary medicine , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom